Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Staccato Alprazolam in Stereotypical Prolonged Seizures
NCT05077904Phase 3Recruiting
- Sponsor
- UCB
- Start
- Dec 2021
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of alprazolam in status epilepticus (SE), sponsored by UCB. Started Dec 2021; status: recruiting.
02
Drugs
alprazolam
03
Conditions
status epilepticus (SE)
Beyond the preview
Go deeper on NCT05077904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05077904.